CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: polypeptide
Accession: CHEBI:15841
browse the term
Definition: A peptide containing ten or more amino acid residues.
Synonyms: exact_synonym: polypeptides
related_synonym: Formula=C4H6N2O3R2(C2H2NOR)n; Polypeptid; polipeptido
alt_id: CHEBI:14860; CHEBI:8314
xref: KEGG:C00403
G
SELE
selectin E
increases expression
EXP
mastoparan results in increased expression of SELE mRNA
CTD
PMID:10769290
NCBI chr 4:81,289,061...81,299,657
G
IL4
interleukin 4
decreases response to substance
EXP
IL4 protein results in decreased susceptibility to Melitten
CTD
PMID:20017192
NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
G
PLA2G1B
phospholipase A2 group IB
increases activity
EXP
Melitten results in increased activity of PLA2G1B protein
CTD
PMID:9092818
NCBI chr14:40,314,520...40,322,315
Ensembl chr14:40,314,520...40,322,315
G
SELE
selectin E
increases expression
EXP
Melitten results in increased expression of SELE mRNA
CTD
PMID:10769290
NCBI chr 4:81,289,061...81,299,657
G
ADCYAP1
adenylate cyclase activating polypeptide 1
multiple interactions
EXP
omega-Conotoxin GVIA inhibits the reaction [ADCYAP1 protein alternative form results in decreased susceptibility to 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid]
CTD
PMID:14662737
NCBI chr 6:105,414,628...105,422,294
Ensembl chr 6:105,414,631...105,422,294
G
OPRM1
opioid receptor mu 1
multiple interactions
EXP
omega-Conotoxin GVIA inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein results in increased transport of Barium]]
CTD
PMID:12031848
NCBI chr 1:12,634,125...12,702,295
Ensembl chr 1:12,528,672...12,702,443
G
VIP
vasoactive intestinal peptide
multiple interactions
EXP
omega-Conotoxin GVIA inhibits the reaction [VIP protein results in decreased susceptibility to 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid]
CTD
PMID:14662737
NCBI chr 1:13,611,786...13,620,250
Ensembl chr 1:13,611,311...13,620,269
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
5007
chemical entity
5007
molecular entity
5006
polyatomic entity
4986
macromolecule
61
polypeptide
6
(12R)-30-ethyl-33-[(1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
0
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
0
(4R)-4-[[(2S)-2-[[[2-(1-amino-2-methylbutyl)-4,5-dihydrothiazol-4-yl]-oxomethyl]amino]-4-methyl-1-oxopentyl]amino]-5-[[(2S,3S)-1-[[(3S,6R,9S,12R,15S,18R,21S)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-15-[(2S)-butan-2-yl]-6-(carboxymethyl)-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-12-(phenylmethyl)-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid
0
Ac-Asp-Lys-Ala-Thr-Ile-Gly-Phe-Glu-Val-Gln-Glu-Glu
0
Ac-Asp-N(6)-(4-bromobenzoyl)-KATIGFEVQEE
0
Ac-Asp-N(6)-(5-chloropentanoyl)-KATIGFEVQEE
0
Ac-Asp-N(6)-(6-bromohexanoyl)-KATIGFEVQEE
0
Ac-Asp-N(6)-(chloroacetyl)-KATIGFEVQEE
0
Ac-Asp-N(6)-(octanoyl)-KATIGFEVQEE
0
Ac-Asp-N(6)-[(2,2,2-trifluoroethoxy)acetyl]-KATIGFEVQEE
0
Ac-Asp-N(6)-[(2-iodophenyl)carbonyl]-KATIGFEVQEE
0
Ac-Asp-N(6)-[(2E)-3-(3-nitrophenyl)prop-2-enoyl]-KATIGFEVQEE
0
Ac-Asp-N(6)-[(2E)-3-(4-chlorophenyl)prop-2-enoyl]-KATIGFEVQEE
0
Ac-Asp-N(6)-[(2E)-3-(m-tolyl)prop-2-enoyl]-KATIGFEVQEE
0
Ac-Asp-N(6)-[2,5-bis(trifluoromethyl)benzoyl]-KATIGFEVQEE
0
Ac-Asp-N(6)-[2-(trifluoromethyl)benzoyl]-KATIGFEVQEE
0
Ac-Asp-N(6)-[3-(trifluoromethyl)benzoyl]-KATIGFEVQEE
0
Ac-Asp-N(6)-[4-(trifluoromethyl)benzoyl]-KATIGFEVQEE
0
Ac-Asp-N(6)-\{(2E)-3-[2-(trifluoromethyl)phenyl]prop-2-enoyl\}-KATIGFEVQEE
0
Ac-Asp-N(6)-\{(2E)-3-[3-(trifluoromethyl)phenyl]prop-2-enoyl\}-KATIGFEVQEE
0
Ac-Asp-N(6)-\{(2E)-3-[4-(trifluoromethyl)phenyl]prop-2-enoyl\}-KATIGFEVQEE
0
Ac-Asp-N(6)-\{3-[2-(trifluoromethyl)phenyl]propanoyl\}-KATIGFEVQEE
0
Arthrofactin
0
CIGB-300
0
DASKALRSSGMP
0
DKATIGFEVQEE
0
DSGEGDFLAEGGGVR
0
ENPAVHFFKNIVTPRTP
0
ENPVVAFFKNIVTPRTP
0
ENPVVHFFFNIVTPRTP
0
ENPVVHFFKNIVTPRTP
0
ENPVVHFFYNIVTPRTP
0
FPAWFTKLYPRT
0
Gonadorelin hydrochloride
0
GsMTx4
0
IPQVWRDWFKLP
0
JNK inhibitor I
0
KGKGKGKGKGENPAVHFFKNIVTPRTP
0
KGKGKGKGKGENPVVAFFKNIVTPRTP
0
KGKGKGKGKGENPVVHFFFNIVTPRTP
0
KGKGKGKGKGENPVVHFFKNIVTPRTP
0
KGKGKGKGKGENPVVHFFYNIVTPRTP
0
LSM-37009
0
LSM-37015
0
LSM-37045
0
LSM-37094
0
LSM-37129
0
LSM-37138
0
LSM-37175
0
LSM-37192
0
LSM-37213
0
Mirabamide C
0
Mirabamide G
0
Mirabamide H
0
N-Ac-Asp-N(6)-lipoyl-KATIGFEVQEE
0
N-acetyl-Asp-N(6)-[lipoyl]-Lys-Ala-Thr-Ile-Gly-Phe-Glu-Val-Gln-Glu-Glu
0
Neurokinin A
0
Neurokinin B
0
P-factor
0
QINTAKWWKTHF
0
QSPSYPDREYSDEDRQIKQMLHQECPRL-NH2
0
Rac1 Inhibitor W56
0
STAT3 inhibitor peptide
0
Streptomyces coelicolor calcium-dependent antibiotic CDA4b
0
VSWKTWFPNLAV
0
Vaby A
0
Vaby B
0
Vaby C
0
Vaby D
0
Vaby E
0
Varv E
0
WHWLQLKPGQPMY
0
YIIKGLFWDPAC +
0
YIIKGVFWDPAC +
0
YSPFHKWFPSMH
0
abarelix
0
afamelanotide
0
albiglutide
0
amoxicilloyl polylysine
0
amyloid-beta +
0
astressin
0
astressin 2B
0
bacitracin A +
0
benzylpenicilloyl polylysine
0
beta-endorphin
0
bivalirudin
0
calcitonin
0
calcitonin (human synthetic)
0
calcitonin (pork natural)
0
calpastatin peptide Ac 184-210
0
carperitide
0
cathelicidin +
0
corticorelin
0
corticotropin
0
corticotropin-releasing hormone +
0
cosyntropin
0
cyanophycin macromolecule +
0
defensin +
0
degarelix
0
dermaseptin s3(1-16)-NH2
0
desirudin
0
elcatonin
0
elf18
0
enfuvirtide
0
exendin-3
0
exendin-4
0
ganirelix
0
gastrin +
0
ghrelin
0
insulin +
0
kisspeptin-54
0
koshikamide A2
0
lantibiotic +
0
lepirudin
0
liraglutide
0
lixisenatide
0
mastoparans +
1
melittin
3
nesiritide
0
nociceptin
0
omega-conotoxin GVIA
3
p-Glu-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe
0
penicilloyl polylysine
0
peptide YY
0
poly(glycyl-L-arginine)
0
pramlintide
0
protein polypeptide chain +
0
secretin human
0
semaglutide
0
sermorelin
0
teduglutide
0
teriparatide
0
terlipressin
0
tesamorelin
0
thymalfasin
0
tirzepatide
0
Path 2
CHEBI ontology
5007
subatomic particle
4998
composite particle
4998
hadron
4998
baryon
4998
nucleon
4998
atomic nucleus
4998
atom
4998
main group element atom
4964
p-block element atom
4961
carbon group element atom
4876
carbon atom
4875
organic molecular entity
4875
organic group
4591
organic divalent group
4589
organodiyl group
4589
carbonyl group
4588
carbonyl compound
4588
carboxylic acid
296
carboacyl group
174
univalent carboacyl group
174
carbamoyl group
171
carboxamide
171
peptide
36
polypeptide
6
(12R)-30-ethyl-33-[(1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
0
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
0
(4R)-4-[[(2S)-2-[[[2-(1-amino-2-methylbutyl)-4,5-dihydrothiazol-4-yl]-oxomethyl]amino]-4-methyl-1-oxopentyl]amino]-5-[[(2S,3S)-1-[[(3S,6R,9S,12R,15S,18R,21S)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-15-[(2S)-butan-2-yl]-6-(carboxymethyl)-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-12-(phenylmethyl)-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid
0
Ac-Asp-Lys-Ala-Thr-Ile-Gly-Phe-Glu-Val-Gln-Glu-Glu
0
Ac-Asp-N(6)-(4-bromobenzoyl)-KATIGFEVQEE
0
Ac-Asp-N(6)-(5-chloropentanoyl)-KATIGFEVQEE
0
Ac-Asp-N(6)-(6-bromohexanoyl)-KATIGFEVQEE
0
Ac-Asp-N(6)-(chloroacetyl)-KATIGFEVQEE
0
Ac-Asp-N(6)-(octanoyl)-KATIGFEVQEE
0
Ac-Asp-N(6)-[(2,2,2-trifluoroethoxy)acetyl]-KATIGFEVQEE
0
Ac-Asp-N(6)-[(2-iodophenyl)carbonyl]-KATIGFEVQEE
0
Ac-Asp-N(6)-[(2E)-3-(3-nitrophenyl)prop-2-enoyl]-KATIGFEVQEE
0
Ac-Asp-N(6)-[(2E)-3-(4-chlorophenyl)prop-2-enoyl]-KATIGFEVQEE
0
Ac-Asp-N(6)-[(2E)-3-(m-tolyl)prop-2-enoyl]-KATIGFEVQEE
0
Ac-Asp-N(6)-[2,5-bis(trifluoromethyl)benzoyl]-KATIGFEVQEE
0
Ac-Asp-N(6)-[2-(trifluoromethyl)benzoyl]-KATIGFEVQEE
0
Ac-Asp-N(6)-[3-(trifluoromethyl)benzoyl]-KATIGFEVQEE
0
Ac-Asp-N(6)-[4-(trifluoromethyl)benzoyl]-KATIGFEVQEE
0
Ac-Asp-N(6)-\{(2E)-3-[2-(trifluoromethyl)phenyl]prop-2-enoyl\}-KATIGFEVQEE
0
Ac-Asp-N(6)-\{(2E)-3-[3-(trifluoromethyl)phenyl]prop-2-enoyl\}-KATIGFEVQEE
0
Ac-Asp-N(6)-\{(2E)-3-[4-(trifluoromethyl)phenyl]prop-2-enoyl\}-KATIGFEVQEE
0
Ac-Asp-N(6)-\{3-[2-(trifluoromethyl)phenyl]propanoyl\}-KATIGFEVQEE
0
Arthrofactin
0
CIGB-300
0
DASKALRSSGMP
0
DKATIGFEVQEE
0
DSGEGDFLAEGGGVR
0
ENPAVHFFKNIVTPRTP
0
ENPVVAFFKNIVTPRTP
0
ENPVVHFFFNIVTPRTP
0
ENPVVHFFKNIVTPRTP
0
ENPVVHFFYNIVTPRTP
0
FPAWFTKLYPRT
0
Gonadorelin hydrochloride
0
GsMTx4
0
IPQVWRDWFKLP
0
JNK inhibitor I
0
KGKGKGKGKGENPAVHFFKNIVTPRTP
0
KGKGKGKGKGENPVVAFFKNIVTPRTP
0
KGKGKGKGKGENPVVHFFFNIVTPRTP
0
KGKGKGKGKGENPVVHFFKNIVTPRTP
0
KGKGKGKGKGENPVVHFFYNIVTPRTP
0
LSM-37009
0
LSM-37015
0
LSM-37045
0
LSM-37094
0
LSM-37129
0
LSM-37138
0
LSM-37175
0
LSM-37192
0
LSM-37213
0
Mirabamide C
0
Mirabamide G
0
Mirabamide H
0
N-Ac-Asp-N(6)-lipoyl-KATIGFEVQEE
0
N-acetyl-Asp-N(6)-[lipoyl]-Lys-Ala-Thr-Ile-Gly-Phe-Glu-Val-Gln-Glu-Glu
0
Neurokinin A
0
Neurokinin B
0
P-factor
0
QINTAKWWKTHF
0
QSPSYPDREYSDEDRQIKQMLHQECPRL-NH2
0
Rac1 Inhibitor W56
0
STAT3 inhibitor peptide
0
Streptomyces coelicolor calcium-dependent antibiotic CDA4b
0
VSWKTWFPNLAV
0
Vaby A
0
Vaby B
0
Vaby C
0
Vaby D
0
Vaby E
0
Varv E
0
WHWLQLKPGQPMY
0
YIIKGLFWDPAC +
0
YIIKGVFWDPAC +
0
YSPFHKWFPSMH
0
abarelix
0
afamelanotide
0
albiglutide
0
amoxicilloyl polylysine
0
amyloid-beta +
0
astressin
0
astressin 2B
0
bacitracin A +
0
benzylpenicilloyl polylysine
0
beta-endorphin
0
bivalirudin
0
calcitonin
0
calcitonin (human synthetic)
0
calcitonin (pork natural)
0
calpastatin peptide Ac 184-210
0
carperitide
0
cathelicidin +
0
corticorelin
0
corticotropin
0
corticotropin-releasing hormone +
0
cosyntropin
0
cyanophycin macromolecule +
0
defensin +
0
degarelix
0
dermaseptin s3(1-16)-NH2
0
desirudin
0
elcatonin
0
elf18
0
enfuvirtide
0
exendin-3
0
exendin-4
0
ganirelix
0
gastrin +
0
ghrelin
0
insulin +
0
kisspeptin-54
0
koshikamide A2
0
lantibiotic +
0
lepirudin
0
liraglutide
0
lixisenatide
0
mastoparans +
1
melittin
3
nesiritide
0
nociceptin
0
omega-conotoxin GVIA
3
p-Glu-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe
0
penicilloyl polylysine
0
peptide YY
0
poly(glycyl-L-arginine)
0
pramlintide
0
protein polypeptide chain +
0
secretin human
0
semaglutide
0
sermorelin
0
teduglutide
0
teriparatide
0
terlipressin
0
tesamorelin
0
thymalfasin
0
tirzepatide
0